CLYM vs MSFT: Which Stock is Better?
Side-by-side comparison of Climb Bio Inc and Microsoft Corporation in 2026
CLYM
Climb Bio Inc
$14.70
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | CLYM | MSFT | Winner |
|---|---|---|---|
| Market Cap | $85.82M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze CLYM
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CLYM or MSFT a better investment?
Comparing CLYM and MSFT: Climb Bio Inc has a market cap of $85.82M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CLYM and MSFT?
CLYM (Climb Bio Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CLYM or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CLYM or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for CLYM.
Which company is more profitable: CLYM or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for CLYM.
Which is the larger company: CLYM or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $85.82M for CLYM.
Should I buy CLYM or MSFT in 2026?
Both CLYM and MSFT have investment merit. CLYM trades at $14.70 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CLYM and MSFT stock?
Key differences: Market Cap ($85.82M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy CLYM or MSFT in 2026?
The choice between CLYM and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CLYM and MSFT?
CLYM (Climb Bio Inc) has a market cap of $85.82M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.